Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Etoposide in Relapsed Ependymoma
NCT00278252Phase 2Unknown
- Sponsor
- Children's Cancer and Leukaemia Group
- Start
- Jul 2001
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of etoposide in ependymoma, sponsored by Children's Cancer and Leukaemia Group. Status: unknown.
02
Drugs
etoposide
03
Conditions
ependymoma
Beyond the preview
Go deeper on NCT00278252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00278252.